Mordechai Aviv Taasiot Beniyah (1973) Ltd (AVIV) Fair Value & Analysis
Industrials · Il · Market cap 284M ILA
Fair value as of: Jun 26, 2026
Analysis
Mordechai Aviv Taasiot Beniyah (1973) Ltd (AVIV) currently trades at 20.02 ILA, while our model-based Fair Value estimate is 18.92 ILA — implying the stock looks roughly 5.5% overvalued today. We read business quality at 95/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Mordechai Aviv Taasiot Beniyah (1973) Ltd. engages in the construction and development of residential and commercial properties in Israel and Hungary. The company offers stone, marble, aluminum, and frame products for residential complexes to build windows, doors, curtain walls, profiles, and others. It also provides frames for use in handrails for stairwells and balconies, supporting walls, kitchen cabinets, electrical and water systems, and planters; and molds and prefabricated elements, such as intermediate surfaces in staircases and walls. In addition, the company offers marble and stone products; and contracting services. Further, it engages in the rental and operation of properties. Mordechai Aviv Taasiot Beniyah (1973) Ltd. was incorporated in 1973 and is based in Jerusalem, Israel.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Mordechai Aviv Taasiot Beniyah (1973) Ltd (AVIV) undervalued?
What is the fair value of AVIV?
What is the quality score of AVIV?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.